DecisionRx Enhances Medication Therapy Optimization
DecisionRx Partners with MedeAnalytics to Power Value-Based Medication Optimization
In a major step forward for healthcare technology, DecisionRx has formed a partnership with MedeAnalytics, a leader in healthcare analytics software. This collaboration will harness the predictive capabilities of MedeAnalytics' Health Fabric™, enabling DecisionRx to quantify the clinical and economic impacts associated with their medication therapy optimization services.
Addition of Predictive Analytics to Patient Care
DecisionRx’s platform focuses on creating personalized prescribing decisions that combine advanced data science, established clinical guidelines, and the expertise of trained pharmacists. The goal is to minimize medication failures, which not only jeopardize patient health but also inflate costs for healthcare payers and providers. With their optimized approach to medication therapy, DecisionRx is reporting significant reductions in healthcare expenses, like over $3,600 annually for Medicare patients and $1,200 for patients below 65.
The Goals and Impact of the Partnership
“Partnering with MedeAnalytics gives us the tools necessary to further assess and communicate the value we provide in our payer contracts,” shared Travis Morgan, President and Co-Founder of DecisionRx. “Our technology is already generating significant cost savings for many patients, and this new alliance enhances our ability to report these savings effectively.”
Healthcare Cost Savings and Patient Outcomes
The integration of MedeAnalytics allows DecisionRx to track and report on essential metrics such as the return on investment for clinical interventions, cost savings, and patient health outcomes. The use of real-world data ensures insights are actionable and relevant, empowering healthcare providers and payers to make informed decisions. Additionally, these metrics support the push for quality improvements and value-based care initiatives, which are becoming increasingly crucial in the healthcare landscape.
Advancements in Healthcare Data Analytics
DecisionRx aims to close the gap that medication failures create in patient care. Steve Grieco, CEO of MedeAnalytics, stated, “We are thrilled to contribute to DecisionRx’s mission as we equip them with analytics capabilities that can track savings and optimize healthcare interventions.”
Technological Integration for Better Care
By combining groundbreaking technologies such as artificial intelligence and machine learning with comprehensive data orchestration, MedeAnalytics allows organizations like DecisionRx to address complex healthcare challenges. This synergy not only enhances resource allocation but ultimately aims to deliver better patient outcomes and streamline population health management.
About MedeAnalytics and DecisionRx
About MedeAnalytics
MedeAnalytics has over three decades of experience in healthcare technology. Their robust data enrichment platform and analytic solutions address the unique challenges of the healthcare industry. The combination of their curated Health Fabric™ and strategic consulting services allows for substantial ROI, driving better healthcare decisions and actions.
About DecisionRx
DecisionRx is committed to improving patient care and reducing overall healthcare costs. Their experienced pharmacists work diligently to make tailored recommendations based on comprehensive data analysis. By focusing on personalized medication therapy optimization, DecisionRx plays a crucial role in mitigating the costly impacts of medication failures.
Frequently Asked Questions
What is the main goal of the partnership between DecisionRx and MedeAnalytics?
The main goal is to enhance medication therapy optimization by combining data-driven insights with clinical interventions to improve patient outcomes and reduce costs.
How does DecisionRx's platform aid in medication optimization?
DecisionRx’s platform utilizes data science, clinical guidelines, and pharmacist expertise to create personalized prescribing solutions that aim to reduce medication failures.
What financial benefits have been reported from DecisionRx’s services?
DecisionRx reports annual savings of over $3,600 for Medicare patients and $1,200 for patients under 65 due to optimized medication therapy.
How does MedeAnalytics support DecisionRx in achieving its goals?
MedeAnalytics provides outcomes analysis capabilities that enable DecisionRx to quantify the effectiveness of their interventions and track savings.
What is the significance of value-based care in this partnership?
Value-based care is crucial as it focuses on delivering quality healthcare outcomes while managing costs, making it essential for both DecisionRx and MedeAnalytics' goals.
